Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Proton Medical Center is a China-based proton radiotherapy institution focused on the diagnosis and treatment of cancer using proton beam therapy and related oncology services. The center was established by Concord Medical together with China-Japan Friendship Hospital and operates as a dedicated proton therapy provider with its own legal entity in Beijing. Its facility has been described as including multiple proton treatment rooms based on IBA's ProteusPLUS system, outpatient and inpatient capabilities, and associated oncology support infrastructure. The organization appears to function primarily as a clinical care delivery business rather than a drug-development biotech company, with academic and clinical research activity centered on radiation oncology and proton therapy.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Proton Medical Center.